Hollsteen

Voices on Palantir

Why people invest, in their words, next to the SEC numbers.

Voices · third-party opinions, not SEC data

Not investment advice. They could be wrong or outdated. See the original source and date; the view may have changed.

Reset

4 of 56 Voices · Deutsch

PLTRDan IvesAnalystJun 29, 2026Bullish

Our summary: Ives argued the market is badly mispricing enterprise AI demand and monetization over the next six to nine months, including for Palantir.

“The market is way mispricing what this demand trend is going to look like”

CNBC article ›
Details ⓘ
Speaker
Dan Ives, Wedbush Securities
Role
Analyst
Source
CNBC
Format
News article
Date
Jun 29, 2026
Checked
Oct 15, 2026

Voice details · not SEC data. As stated on Jun 29, 2026; the view may have changed.

PLTRMichael BurryInvestorApr 10, 2026Skeptical

Our summary: Burry said he still holds long-dated Palantir puts, calling the stock wildly overvalued with a fundamental value well under $50 a share.

“I believe the fundamental value of this company is well under $50/share”

Substack post, via CNBC ›
Details ⓘ
Speaker
Michael Burry, Cassandra Unchained
Role
Investor
Source
CNBC
Format
Newsletter
Date
Apr 10, 2026
Checked
Oct 15, 2026

Voice details · not SEC data. As stated on Apr 10, 2026; the view may have changed.

PLTRJames CakmakInvestorAug 4, 2025MixedOlder statement

Our summary: Cakmak said Palantir is a position investors have to own, but at a smaller size.

CNBC interview ›
Details ⓘ
Speaker
James Cakmak, Clockwise Capital
Role
Investor
Source
CNBC
Format
TV interview
Date
Aug 4, 2025
Checked
Oct 15, 2026

Voice details · not SEC data. As stated on Aug 4, 2025; the view may have changed.

PLTRPaul MeeksInvestorFeb 20, 2025SkepticalOlder statement

Our summary: Meeks said Palantir's fundamentals are strong but its valuation is egregious.

“egregiously expensive”

CNBC interview ›
Details ⓘ
Speaker
Paul Meeks, Harvest Portfolio Management
Role
Investor
Source
CNBC
Format
TV interview
Date
Feb 20, 2025
Checked
Oct 15, 2026

Voice details · not SEC data. As stated on Feb 20, 2025; the view may have changed.

Correction or removal request: hello@hollsteen.com · never used for numbers or citations.